Literature DB >> 33489515

Antimicrobial-Resistant Bacteria and Prescription of Antibiotics at a Tertiary Care Hospital in Riyadh, Saudi Arabia.

Anbar Aldawsari1, Kamilia Tawfik2, Ibrahim Al-Zaagi1.   

Abstract

Purpose The purpose of the study was to assess the bacterial resistance and annual antibiotic consumption at a tertiary care hospital in Riyadh, Saudi Arabia over a two-year period. Methods This retrospective cohort study was conducted at a tertiary care hospital in Riyadh, Saudi Arabia from January 1, 2016, to December 31, 2017. Results The results showed that there was no significant difference between 2016 and 2017 data regarding patient characteristics like bed occupancy rate, the average length of stay, and the number of admissions; the same was true for bacterial characteristics like the number of bacteria, percentage of isolates in the group, and multidrug resistance (MDR) percentage (p: >0.05). Between 2016 and 2017, there was a slight reduction in the sensitivity of Escherichia​​​ coli (E. coli) carbapenem-resistant Enterobacteriaceae (CRE) (97%, 86%) and Klebsiella pneumoniae (K. pneumoniae) CRE (80%, 76%) towards colistin. There was also a decrease in the sensitivity of Acinetobacter baumannii (A. baumannii) multidrug-resistant organism (MDRO) from 42% to 29% against tigecycline, but an increase in the sensitivity of K. pneumoniae CRE (33%, 50%) and E. coli CRE (76%, 82%). The percentage of MDR strains in gram-positive bacteria showed that more than half of Staphylococcus aureus (S. aureus) were methicillin-resistant (61%, 59%) in 2016 and 2017 respectively. There was a reduction in the percentage of MDR strains in some gram-negative bacteria like Pseudomonas aeruginosa (P. aeruginosa) MDRO (24%, 19%),E. coli extended-spectrum beta-lactamases (ESBL) (56%, 50%), E. coli CRE (4%, 1%), K. pneumoniae CRE (49%, 33%), A. baumannii CRE (90%, 76%), and Proteus mirabilis​​​​​​​ (P. mirabilis) ESBL (54%, 50%). Conclusion MDRO bacteria are very common in the hospital where the study was conducted. Immediate action is required to tackle this problem.
Copyright © 2020, Aldawsari et al.

Entities:  

Keywords:  antibiotic; infection; infections; multidrug resistance organism; prescription; tertiary hospital

Year:  2020        PMID: 33489515      PMCID: PMC7805534          DOI: 10.7759/cureus.12098

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  15 in total

1.  Gram-negative bacterial resistance: evolving patterns and treatment paradigms.

Authors:  Marin H Kollef
Journal:  Clin Infect Dis       Date:  2005-02-15       Impact factor: 9.079

2.  Antibiotic resistance-the need for global solutions.

Authors:  Ramanan Laxminarayan; Adriano Duse; Chand Wattal; Anita K M Zaidi; Heiman F L Wertheim; Nithima Sumpradit; Erika Vlieghe; Gabriel Levy Hara; Ian M Gould; Herman Goossens; Christina Greko; Anthony D So; Maryam Bigdeli; Göran Tomson; Will Woodhouse; Eva Ombaka; Arturo Quizhpe Peralta; Farah Naz Qamar; Fatima Mir; Sam Kariuki; Zulfiqar A Bhutta; Anthony Coates; Richard Bergstrom; Gerard D Wright; Eric D Brown; Otto Cars
Journal:  Lancet Infect Dis       Date:  2013-11-17       Impact factor: 25.071

3.  Combating antimicrobial resistance: policy recommendations to save lives.

Authors:  Brad Spellberg; Martin Blaser; Robert J Guidos; Helen W Boucher; John S Bradley; Barry I Eisenstein; Dale Gerding; Ruth Lynfield; L Barth Reller; John Rex; David Schwartz; Edward Septimus; Fred C Tenover; David N Gilbert
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

4.  PME-1-producing Pseudomonas aeruginosa in Qatar.

Authors:  Hosam M Zowawi; Emad Ibrahim; Melanie W Syrmis; Alexander M Wailan; Atqah AbdulWahab; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2015-04-13       Impact factor: 5.191

5.  National surveillance of antimicrobial resistance among Gram-positive bacteria in Saudi Arabia.

Authors:  Atef M Shibl; Ziad A Memish; Abdelmageed M Kambal; Yazid A Ohaly; Abdulrahman Ishaq; Abiola C Senok; David M Livermore
Journal:  J Chemother       Date:  2013-12-06       Impact factor: 1.714

6.  Plasmid-mediated colistin resistance in Escherichia coli from the Arabian Peninsula.

Authors:  Ágnes Sonnevend; Akela Ghazawi; Manaf Alqahtani; Atef Shibl; Wafa Jamal; Rayhan Hashmey; Tibor Pal
Journal:  Int J Infect Dis       Date:  2016-08-25       Impact factor: 3.623

Review 7.  β-Lactamase production in key gram-negative pathogen isolates from the Arabian Peninsula.

Authors:  Hosam M Zowawi; Hanan H Balkhy; Timothy R Walsh; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

8.  Risk factors of nasal carriage of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus among health care staff in a teaching hospital in central Saudi Arabia.

Authors:  Ohoud S Al-Humaidan; Talat A El-Kersh; Raid A Al-Akeel
Journal:  Saudi Med J       Date:  2015-09       Impact factor: 1.484

Review 9.  World Health Organization Ranking of Antimicrobials According to Their Importance in Human Medicine: A Critical Step for Developing Risk Management Strategies to Control Antimicrobial Resistance From Food Animal Production.

Authors:  Peter J Collignon; John M Conly; Antoine Andremont; Scott A McEwen; Awa Aidara-Kane; Yvonne Agerso; Antoine Andremont; Peter Collignon; John Conly; Tran Dang Ninh; Pilar Donado-Godoy; Paula Fedorka-Cray; Heriberto Fernandez; Marcelo Galas; Rebecca Irwin; Beth Karp; Gassan Matar; Patrick McDermott; Scott McEwen; Eric Mitema; Richard Reid-Smith; H Morgan Scott; Ruby Singh; Caroline Smith DeWaal; John Stelling; Mark Toleman; Haruo Watanabe; Gun-Jo Woo
Journal:  Clin Infect Dis       Date:  2016-07-20       Impact factor: 9.079

Review 10.  Strategies to minimize antibiotic resistance.

Authors:  Chang-Ro Lee; Ill Hwan Cho; Byeong Chul Jeong; Sang Hee Lee
Journal:  Int J Environ Res Public Health       Date:  2013-09-12       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.